BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rumanti AP, Maruf A, Liu H, Ge S, Lei D, Wang G. Engineered bioresponsive nanotherapeutics: recent advances in the treatment of atherosclerosis and ischemic-related disease. J Mater Chem B 2021;9:4804-25. [PMID: 34085084 DOI: 10.1039/d1tb00330e] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hu CJ, Wang YW, Huang WX, Xia YB. E prostanoid receptor-3 promotes oxidized low-density lipoprotein-induced human aortic smooth muscle cells inflammation. ESC Heart Fail 2022. [PMID: 36578105 DOI: 10.1002/ehf2.14264] [Reference Citation Analysis]
2 Obaid EAMS, Wu S, Zhong Y, Yan M, Zhu L, Li B, Wang Y, Wu W, Wang G. pH-Responsive hyaluronic acid-enveloped ZIF-8 nanoparticles for anti-atherosclerosis therapy. Biomater Sci 2022. [PMID: 35858474 DOI: 10.1039/d2bm00603k] [Reference Citation Analysis]
3 Zhao R, Ning X, Wang M, Wang H, Xing G, Wang L, Lu C, Yu A, Wang Y. A ROS-Responsive Simvastatin Nano-Prodrug and its Fibronectin-Targeted Co-Delivery System for Atherosclerosis Treatment. ACS Appl Mater Interfaces 2022;14:25080-92. [PMID: 35618653 DOI: 10.1021/acsami.2c02354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]